ArticleThe Journal of antimicrobial chemotherapy2026
Sustaining stewardship: longitudinal evaluation of an integrated antimicrobial programme in the ICU.
Article in The Journal of antimicrobial chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the long-term sustainability and impact of an integrated electronic medical record-driven antimicrobial stewardship (AMS) ward round in an ICU at a tertiary referral hospital. The study assessed antimicrobial prescribing patterns, acceptance of stewardship recommendations, and antimicrobial consumption over 7 years.
methodsA prospective review commenced with implementation of the ICU-AMS ward round at Austin Health in 2017. When AMS recommendations were given, data were collected including patient demographics, antimicrobial prescribing, classification of recommendation, and acceptance. Antimicrobial use was assessed via DDDs per occupied bed day per month and analysed using interrupted time series analysis. Logistic regression examined patient and clinician factors associated with recommendation acceptance.
resultsOver 7 years, 9163 AMS recommendations were made for 4610 patients. Recommendation acceptance was high, with antibiotic escalation the most accepted (95%) and discontinuation least accepted (82%). Recommendations were more likely to be accepted in immunocompromised (OR 1.31, P = 0.003) and non-surgical patients (OR 1.31, P < 0.001). Recommendations provided by AMS physicians who identified as men were more likely to be accepted (OR 1.23, P = 0.003). Antimicrobial consumption trends showed significant decreases in piperacillin/tazobactam, meropenem, ciprofloxacin and vancomycin use post-implementation. Amoxicillin/clavulanate use increased, suggesting potential compensatory prescribing.
conclusionsThis study demonstrates the long-term effectiveness and sustainability of an ICU-AMS programme, achieving high recommendation acceptance and sustained reductions in broad-spectrum antimicrobial use. Continued efforts should focus on optimizing stewardship practices, addressing barriers to acceptance, and evaluating compensatory prescribing patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.